Geom
Geom (ゲオム株式会社) is a Tokyo-based AI healthcare company that develops DeCaAI, a proprietary BERT-CRF prediction system for dementia behavioral symptoms, serving long-term care facilities, healthcare providers, and care-tech companies in Japan and China.
- Company typePrivate
- Founded2022
- HeadquartersTokyo, Japan
- Headcount—
- GTM typeB2B
- OfferingSoftware
What Geom does
Geom (ゲオム株式会社) is a Tokyo-based AI healthcare company founded in 2022 that develops predictive technology for dementia care. Its core product, DeCaAI (Dementia Care-Assist AI), uses a proprietary BERT-CRF natural language processing model trained on a domain-specific knowledge base of 500,443+ care methods, 1,734 BPSD (Behavioral and Psychological Symptoms of Dementia) interventions, and 2,833 dictionary terms to anticipate behavioral episodes 30-60 minutes in advance. The system, which reports 93.2% prediction accuracy, a 70% BPSD suppression rate, and a 47.3% reduction in emergency response time, was developed through an AMED-funded research project (2020-2022) and is protected by Japanese patent No. 7285046. DeCaAI documentation integrates with the F-SOAIP Japanese care documentation standard, embedding outputs directly into existing facility workflows.
The company's product portfolio extends beyond DeCaAI to include Geotti (ゲオッチ), a concierge document creation service for care providers; LOVOT-with-DeCaAI, a hardware-software bundle integrating DeCaAI into GROOVE X's companion robot (pre-market); an AI Vital Sign Anomaly Detection module under development; and AccorDex (Privacy Governance as a Service), a blockchain-based data sovereignty platform. Revenue mechanics appear to combine per-facility SaaS subscriptions for DeCaAI, transactional fees for Geotti, and licensing arrangements. Customer segments include long-term care facilities, healthcare providers, and other care-tech companies in Japan, with a China market entry initiated through Itochu Corporation at CIIE 2024.
Geographically, Geom is positioned at the intersection of Japan's national nursing care infrastructure modernization (aligned with the 2026 roadmap) and the China dementia care market. The company actively engages in regulatory policy submissions and was featured in Nihon Keizai Shimbun in March 2025. Strategic partners include Itochu Corporation (international distribution) and GROOVE X (robotics integration), with the Ministry of Health, Labour and Welfare endorsing the LOVOT-with-DeCaAI pre-launch at the Osaka-Kansai Expo 2025.
Geom firmographics
Firmographics- Name
- Geom
- Legal name
- ゲオム株式会社
- Website
- https://geom-hd.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Short description
- Geom (ゲオム株式会社) is a Tokyo-based AI healthcare company that develops DeCaAI, a proprietary BERT-CRF prediction system for dementia behavioral symptoms, serving long-term care facilities, healthcare providers, and care-tech companies in Japan and China.
- Ownership category
- akta.pro rank
Geom industry classification
Industry- Product category
- Dementia Care AI Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Memory Care Care Management & Navigation (Dementia Care Coordination) (HLADACAJ)
- akta.pro secondary industries
- Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection) (HLACAFAE), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Geriatric, Frailty & Fall-Prevention Remote Monitoring (HLALAFAI), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)
Keywords
Where Geom is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Geom business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- DeCaAI Software Licensing: Subscription-based licensing fees for AI care management platform. Pricing includes initial setup (hardware, configuration) plus recurring license fees based on number of patients and care staff using the system.
- Geotti Concierge Service (資料作成代行): Subscription service providing outsourced document creation and SNS management for care facilities. Targets non-core administrative tasks like manuals, promotional materials, and recruitment documents.
- Privacy Governance as a Service: Data protection and governance platform services leveraging blockchain technology for healthcare data authenticity and access management.
- API Integration Services: Technical integration services for care software companies seeking to incorporate DeCaAI functionality into their existing products via API connectivity.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | One time | Initial Setup Fee (初期費) |
| Subscription | Monthly | License Fee (ライセンス費) |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Geom product offering
Product offeringCore offering
Geom develops and sells AI software for nursing care facilities, centered on DeCaAI (Dementia Care-Assist AI System), which predicts BPSD (Behavioral and Psychological Symptoms of Dementia) 30-60 minutes in advance and recommends care interventions using NLP and time-series vital sign analysis. The company also sells Geotti, a subscription concierge service that outsources non-core document creation for care facilities, and Privacy Governance as a Service, a blockchain-based platform for healthcare data authenticity and traceability.
Product overview
Geom offers a unified AI-powered dementia care platform centered on DeCaAI (Dementia Care-Assist AI system), an iOS-based BPSD prediction and care recommendation system. The portfolio includes LOVOT with DeCaAI (communication robot integration), ゲオッチ (document creation/SNS subscription service), AI vital sign anomaly detection, and Privacy Governance as a Service (blockchain-based data management). The core DeCaAI system provides 30/60-minute BPSD predictions, voice-input care records with automatic F-SOAIP structuring, and real-time care recommendations, while the blockchain platform enables secure secondary use of care data.
Differentiator
Problem solved
Functional benefit
Brands
- DeCaAI (Dementia Care-Assist AI system): AI system that predicts BPSD (behavioral and psychological symptoms of dementia) 30-60 minutes in advance and provides appropriate care methods
- ゲオッチ (Geotti)
- Privacy Governance as a Service
- AccorDex
- GEOM.ai
- F-SOAIP
Products and services
- DeCaAI (Dementia Care-Assist AI System)
- Geotti (ゲオッチ) Concierge Service
Quantifiable outcome
- BPSD onset suppression rate of 70% achieved in demonstration experiments
- +2 more outcomes
Companies that use Geom
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Geom technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability9 records
Feature6 records
Geom partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, minor and secondary.
- 伊藤忠商事株式会社 (Itochu Corporation)coreFull cooperation partner for CIIE 2024 exhibition showcasing DeCaAI and LOVOT integration. Itochu Corporation, a major Japanese trading company, facilitated the company's participation in China's largest import expo and provided support for international expansion efforts into the Chinese market.
- GROOVE X株式会社 (GROOVE X)coreStrategic partnership for integrating DeCaAI with LOVOT communication robots. Joint product 'LOVOT with DeCaAI' combines emotional robotics with AI-powered dementia care prediction and intervention capabilities.
- 一般社団法人 新経済連盟 (New Economy Federation)minorIndustry association membership enabling policy advocacy. Company submitted opinions on AI regulations through the federation regarding data authenticity requirements and privacy protection in AI development.
- 日本医療研究開発機構 (AMED)coreRecipient of AMED funding for dementia AI development project 'Development and Implementation of AI-IoT Services for Dementia Care to Reduce Care Burden through BPSD Prediction and Prevention' (2020-2022, Project No. JP22us042001, Representative:山口晴保)
- 厚生労働省 (Ministry of Health, Labour and Welfare)coreSelected for Ministry-sponsored nursing robot exhibition program at 2025 Osaka/Kansai World Expo. The 'Health and Well-being Week' exhibition booth showcases pre-release LOVOT with DeCaAI product under the ministry's initiative for nursing technology promotion.
- Care Software Companies (unspecified)secondaryAPI integration partnerships with care software developers to enable DeCaAI functionality within existing care management systems, allowing customers of partner companies to access BPSD prediction and care recommendation features.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Geom competitors and assessment
Company assessmentDirect peers
- Cyberdyne: Japanese healthcare robotics and cybernics company developing assistive devices for elderly and disabled populations. Comparable as a Japan-based tech company commercializing AI/robotics solutions for the care market.
- EarBrain: Japanese startup developing AI for dementia and cognitive assessment, with similar focus on early detection of cognitive decline. Direct peer in the Japanese dementia-AI category with overlapping scientific and commercial ambitions.
- GROOVE X: Japanese maker of LOVOT companion robots; integrated with Geom's DeCaAI for the 'LOVOT with DeCaAI' product. Operates at the intersection of emotional robotics and AI-driven care, directly comparable to Geom's robotics-AI hybrid direction.
- Silk. Japanese care-tech startup offering AI-driven solutions for elderly care facilities, including documentation and care planning tools. Direct competitor for DeCaAI's nursing facility buyer personas.
Broad incumbents
- AIST Solutions: Commercialization arm of Japan's National Institute of Advanced Industrial Science and Technology (AIST), bringing Japanese AI/robotics research to market. Comparable as a Japan-based conduit between AI research and care-sector commercialization.
- Itochu Corporation: Major Japanese trading conglomerate and Geom's distribution partner. Functions as a broad incumbent enabling Geom's international expansion into China and other markets via trading-house networks.
Emerging players
- Cogstate: Cognitive assessment technology company providing computerized tests for dementia and Alzheimer's detection. Comparable as a tech-enabled dementia assessment platform, though focused on testing rather than in-facility BPSD prediction.
- Linus Health: US-based digital health company using AI for cognitive assessment and early dementia detection. Comparable in applying AI to dementia/cognitive assessment, though focused on detection rather than ongoing BPSD prediction in care settings.
- Ubie: Japanese AI health-tech company providing symptom checking and clinical workflow tools. Comparable as a Japan-based AI health platform, though primarily consumer/clinical rather than dementia-specific.
- Ory Laboratory: Japanese avatar/robotics company (OriHime) providing communication tools for elderly and disabled populations. Comparable as a Japan-based care-focused technology company combining AI/robotics for elderly populations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Geom financial estimates
Financial estimateRevenue estimate
Valuation estimate
Geom leadership team
Management profileNumber of profiles
Profiles1 record
Geom funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Geom M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Geom
What does Geom do?
Geom develops and sells AI software for nursing care facilities, centered on DeCaAI (Dementia Care-Assist AI System), which predicts BPSD (Behavioral and Psychological Symptoms of Dementia) 30-60 minutes in advance and recommends care interventions using NLP and time-series vital sign analysis. The company also sells Geotti, a subscription concierge service that outsources non-core document creation for care facilities, and Privacy Governance as a Service, a blockchain-based platform for healthcare data authenticity and traceability.
Is Geom a public or private company?
Geom is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Geom founded?
Geom was founded in 2022.
Where is Geom based?
Geom is headquartered in Tokyo, Japan, in the Asia region.
How does Geom make money?
Four revenue lines are on record. DeCaAI Software Licensing is the primary driver. The others are geotti Concierge Service (資料作成代行), privacy Governance as a Service and API Integration Services.
Who are Geom's main competitors?
Direct peers on record are Cyberdyne, EarBrain, GROOVE X and Silk.. Broad incumbents are AIST Solutions and Itochu Corporation. Emerging players are Cogstate, Linus Health, Ubie and Ory Laboratory.
Does Geom have an API?
Yes. DeCaAI supports API integration with nursing care record software (介護記録ソフト). Care tech companies can integrate DeCaAI's AI functionality into their existing products via API connection. This enables care software to leverage DeCaAI's BPSD prediction and care recommendation capabilities.
What industry is Geom in?
Geom's product category is Dementia Care AI Software. Its primary akta.pro industry code is HLADACAJ, Memory Care Care Management & Navigation (Dementia Care Coordination), with a secondary code of HLACAFAE, Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection). Its NAICS code is 518 and its SIC code is 7370.